Stillwater Investment Management (Minnesota)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Stillwater Investment Management (Minnesota)'s BMY Position: Q4 2017 in Review
Stillwater Investment Management (Minnesota) sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 3,162 shares — an estimated $202K sold.
Stillwater Investment Management (Minnesota) first reported a position in BMY in Q4 2014 and held it in 8 quarters. The position peaked at $255K in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Stillwater Investment Management (Minnesota) reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
- Stillwater Investment Management (Minnesota) sold 3,162 Bristol-Myers Squibb shares in Q4 2017, an estimated $202K.
- Stillwater Investment Management (Minnesota) first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 8 quarters.
- Stillwater Investment Management (Minnesota)'s Bristol-Myers Squibb position peaked at $255K in Q2 2016.
- 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Stillwater Investment Management (Minnesota)'s 13F filing for Q4 2017, filed 4 Jan 2018.